JKSE
JKSE
LCGP vs LABS — which is the better stock?
Eureka Prima Jakarta Tbk. (LCGP) compared against UBC Medical Indonesia Tbk. (LABS). Data through 2019-04-30.
LCGP
JKSEEureka Prima Jakarta Tbk.
| Last close | 114 |
| 1Y return | |
| 3Y return | |
| 5Y return | |
| P/E ratio | — coming soon |
| Dividend yield | — coming soon |
| Sector | JKSE |
| Data since | 2007-07-13 |
LABS
JKSEUBC Medical Indonesia Tbk.
| Last close | 170 |
| 1Y return | +20.57% |
| 3Y return | — |
| 5Y return | — |
| P/E ratio | — coming soon |
| Dividend yield | — coming soon |
| Sector | JKSE |
| Data since | 2024-07-10 |
Shared price chart (normalized to 100)
Loading chart…
Both series are normalized to 100 at the start of the selected range so absolute price differences don't dominate the comparison.
Why compare LCGP vs LABS?
LCGP and LABS are both JKSE-listed stocks that often come up together when investors weigh Indonesian equity exposure. Looking at them side by side — last close, 1Y/3Y/5Y returns, and sector tag — makes it easier to pick the one that matches your portfolio's thesis. The shared chart above re-bases both tickers to 100 at the start of the range so the slope of each line directly answers "which one grew faster?".